Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility
- 1 July 1991
- journal article
- research article
- Published by Springer Nature in Zeitschrift für Krebsforschung und Klinische Onkologie
- Vol. 117 (S4) , S129-S134
- https://doi.org/10.1007/bf01613217
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II studyZeitschrift für Krebsforschung und Klinische Onkologie, 1991
- The effect of route of administration and fractionation of dose on the metabolism of ifosfamideCancer Chemotherapy and Pharmacology, 1990
- Ifosfamide by continuous infusion to prevent encephalopathyThe Lancet, 1990
- A Randomized Study of Inpatient versus Outpatient Continuous Intravenous Infusion Chemotherapy: Psychosocial AspectsSelective Cancer Therapeutics, 1989
- IfosamideJNCI Journal of the National Cancer Institute, 1988
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- A simple quantitative HPLC assay for ifosfamide in biological fluidsBiomedical Chromatography, 1986
- Ifosfamide-pharmacology, safety and therapeutic potentialCancer Treatment Reviews, 1985
- Chemotherapeutische Behandlungsmöglichkeiten bei fortgeschrittenen SarkomenDeutsche Medizinische Wochenschrift (1946), 1981
- Quantitative GLC Determination of Cyclophosphamide and Isophosphamide in Biological SpecimensJournal of Pharmaceutical Sciences, 1974